rs200689054

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_203447.4(DOCK8):​c.52A>G​(p.Arg18Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000163 in 1,583,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R18K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00094 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000080 ( 0 hom. )

Consequence

DOCK8
NM_203447.4 missense, splice_region

Scores

2
5
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 4.38

Publications

1 publications found
Variant links:
Genes affected
DOCK8 (HGNC:19191): (dedicator of cytokinesis 8) This gene encodes a member of the DOCK180 family of guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with Rho GTPases and are components of intracellular signaling networks. Mutations in this gene result in the autosomal recessive form of the hyper-IgE syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Jun 2010]
DOCK8-AS1 (HGNC:26436): (DOCK8 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.031262726).
BP6
Variant 9-215028-A-G is Benign according to our data. Variant chr9-215028-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 429234.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00094 (143/152186) while in subpopulation AFR AF = 0.0033 (137/41498). AF 95% confidence interval is 0.00285. There are 0 homozygotes in GnomAd4. There are 62 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK8NM_203447.4 linkc.52A>G p.Arg18Gly missense_variant, splice_region_variant Exon 1 of 48 ENST00000432829.7 NP_982272.2 Q8NF50-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK8ENST00000432829.7 linkc.52A>G p.Arg18Gly missense_variant, splice_region_variant Exon 1 of 48 1 NM_203447.4 ENSP00000394888.3 Q8NF50-1

Frequencies

GnomAD3 genomes
AF:
0.000940
AC:
143
AN:
152076
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00331
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000187
AC:
36
AN:
192762
AF XY:
0.000138
show subpopulations
Gnomad AFR exome
AF:
0.00336
Gnomad AMR exome
AF:
0.000129
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000234
Gnomad OTH exome
AF:
0.000205
GnomAD4 exome
AF:
0.0000804
AC:
115
AN:
1431018
Hom.:
0
Cov.:
112
AF XY:
0.0000675
AC XY:
48
AN XY:
711260
show subpopulations
African (AFR)
AF:
0.00295
AC:
92
AN:
31136
American (AMR)
AF:
0.000117
AC:
5
AN:
42690
Ashkenazi Jewish (ASJ)
AF:
0.0000393
AC:
1
AN:
25466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38030
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5616
European-Non Finnish (NFE)
AF:
0.00000181
AC:
2
AN:
1103674
Other (OTH)
AF:
0.000236
AC:
14
AN:
59432
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000940
AC:
143
AN:
152186
Hom.:
0
Cov.:
34
AF XY:
0.000833
AC XY:
62
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00330
AC:
137
AN:
41498
American (AMR)
AF:
0.000196
AC:
3
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68004
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000281
Hom.:
0
Bravo
AF:
0.00102
ESP6500AA
AF:
0.000894
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000238
AC:
27
Asia WGS
AF:
0.000290
AC:
1
AN:
3466

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Oct 07, 2015
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jan 31, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -

Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
25
DANN
Benign
0.97
DEOGEN2
Uncertain
0.51
D
Eigen
Benign
0.12
Eigen_PC
Benign
0.054
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.92
D
M_CAP
Pathogenic
0.57
D
MetaRNN
Benign
0.031
T
MetaSVM
Benign
-1.1
T
PhyloP100
4.4
PrimateAI
Uncertain
0.70
T
Sift4G
Uncertain
0.018
D
Polyphen
0.019
B
Vest4
0.69
MVP
0.64
ClinPred
0.039
T
GERP RS
3.7
PromoterAI
0.070
Neutral
Varity_R
0.18
gMVP
0.51
Mutation Taster
=251/49
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200689054; hg19: chr9-215028; API